Open access · CC-BY
via OpenAlex
Metformin-Treatment Option for Social Impairment? An Open Clinical Trial to Elucidate the Effects of Metformin Treatment on Steroid Hormones and Social Behavior
Benedikt Andreas Gasser, Johann Kurz, Samuel Buerki, Markus Georg Mohaupt
Life · 2022 · ▲ 7 citations
Abstract
BACKGROUND: Social behavior is mediated by steroid hormones, whereby various lines of evidence indicate that metformin might improve the symptoms of social withdrawal. This directly yields to the aim of the study to correlate the impact of metformin treatment on the potential alterations in steroid hormone homeostasis, which is ultimately impacting social behavior. Therefore, urinary samples of patients before and after treatment with metformin will be correlated to social behavior to elucidate potential changes in steroid hormone profiles and social behavior. MATERIAL AND METHODS: An observational study in healthy adults with a new indication for metformin. Steroid hormone analysis, including the most prominent androgen, estrogen, progesterone, aldosterone, corticosterone, cortisone and cortisol metabolites analyzed with gas chromatography-mass spectrometry and a questionnaire on social behavior (Autism Spectrum Questionnaire (AQ)) will be administered prior to and after around a 12-week phase of metformin treatment. DISCUSSION: It is likely that due to different pathophysiological mechanisms such as an effect on the respiratory chain in mitochondria or via AMP-activated protein kinase, a general alteration of steroid hormone levels can be detected prior to post treatment. The encompassing measurement of steroid hormones shall give hints concerning the involvement of specific cascades yielding potential pharmacological targets for future research.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/life12070998
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Gasser, B.A., Kurz, J., Buerki, S., & Mohaupt, M.G. (2022). Metformin-Treatment Option for Social Impairment? An Open Clinical Trial to Elucidate the Effects of Metformin Treatment on Steroid Hormones and Social Behavior. <em>Life</em>. https://doi.org/10.3390/life12070998
Vancouver
Gasser BA, Kurz J, Buerki S, Mohaupt MG. Metformin-Treatment Option for Social Impairment? An Open Clinical Trial to Elucidate the Effects of Metformin Treatment on Steroid Hormones and Social Behavior. Life. 2022. doi:10.3390/life12070998.
BibTeX
@article{benedikt2022Metfor,
title = {Metformin-Treatment Option for Social Impairment? An Open Clinical Trial to Elucidate the Effects of Metformin Treatment on Steroid Hormones and Social Behavior},
author = {Benedikt Andreas Gasser and Johann Kurz and Samuel Buerki and Markus Georg Mohaupt},
journal = {Life},
year = {2022},
doi = {10.3390/life12070998},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Vanderbilt University Medical Center 2026
Open access · US-GOV
Cholinergic Deep Brain Stimulation for Alzheimer's Disease
Meridigen Biotech Co., Ltd. 2021
Open access · US-GOV
A Phase I, Open Label, Dose Escalation Study to Evaluate the Safety and Tolerability After Intravenous Infusion of UMC119-06-05 in Elderly Subjects With Mild to Moderate Frailty Syndrome.
VA Office of Research and Development 2019
Open access · US-GOV
Optimizing Outcomes for Older Veterans With Chronic Low Back Pain Syndrome: Aging Back Clinics
BMC Geriatrics 2008
Open access · CC-BY
Frailty Intervention Trial (FIT)
Ottawa Hospital Research Institute 2002
Open access · US-GOV
Creation, Evaluation and Validation of a Preoperative Frailty Index Using Health Administrative Data: a Population-based Cohort Study
Our Lady's Hospice and Care Services 2023
Open access · US-GOV